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Abstract
The principles of management of the laryngeal cancer have evolved over the recent past with
emphasis on organ preservation. These developments have paralleled technological advancements
as well as refinement in the surgical technique. The surgeons are able to maintain physiological
functions of larynx namely speech, respiration and swallowing without compromising the loco-
regional control of cancer in comparison to the more radical treatment modalities. A large number
of organ preservation surgeries are available to the surgeon; however, careful assessment of the
stage of the cancer and selection of the patient is paramount to a successful outcome. A
comprehensive review of various organ preservation techniques in vogue for the management of
laryngeal cancer is presented.
Introduction
Laryngeal cancer accounts for 10,000 new cases in USA
per year and 1% cancer related mortality. [1] In Australia,
584 cases of laryngeal cancer were reported in 2001, of
which 90% were male patients. It accounted for 247
deaths in the same year. [2]
Traditionally, the treatment for laryngeal cancer included
total laryngectomy and radiotherapy either used alone or
in combination. The last three decades have seen signifi-
cant technological advances in voice rehabilitation, deliv-
ery of radiation as well as development and
popularisation of conservative surgical techniques. This
has allowed the focus to shift to 'organ preservation.'
Maintenance of quality of life and minimising adverse
effects is now considered an important therapeutic goal
irrespective of the stage of disease and the choice of treat-
ment modality.
While considering organ preservation, it is important to
realise that maintenance of the local anatomy may not
translate into a good functional outcome. Complications
such as dysphagia, aspiration, poor voice and airway com-
promise can undermine an oncologically sound conserv-
ative treatment modality. Hence, organ preservation
laryngeal surgery has been defined as a combination of
procedures that remove a portion of larynx while main-
taining the physiological functions of speech, swallowing
and respiration without compromising local control and
cure rates or the need for a permanent tracheostoma. [3]
Numerous choices are available for treatment of various
subsets of laryngeal cancer with comparable loco-regional
control and survival rates. It emphasises the role of a
multi-disciplinary team lead by an ENT surgeon and com-
prising of a plastic surgeon, radiotherapist, medical oncol-
ogist, speech therapist and dietician to choose the
modality that is most suitable to the patient's need and
expectations. In this paper, we discuss the concepts, tech-
niques and role of contemporary organ preservation
modalities for the management of laryngeal cancer.
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Principles of organ preservation
[see figure 1]
The success of any organ preservation treatment modality
rests on achieving a balance between effective loco-
regional cancer control and maximal functional outcome.
The surgeon who endeavours to undertake organ preser-
vation surgery should: (a) have a thorough understanding
of the static and dynamic anatomy of larynx; (b) accu-
rately assess the cancer both clinically and radiologically;
(c) and have the training to competently perform the cho-
sen surgical technique.
The principles of organ preservation surgery [4] are:
1. Local control: regular and close follow up of the
patient is imperative as changes in laryngeal topogra-
phy with organ preservation techniques can make
early detection of residual/recurrent disease difficult.
2. Accurate assessment of tumour extent- both surface
spread and three dimensional tumour load rather
than relying on the T-stage of the cancer. The draw-
backs of current T-staging system will be discussed
subsequently.
3. The Cricoarytenoid unit as the basic functional unit-
traditionally, surgeons have focussed on the glottis/
vocal cords as the key to phonatory and sphincteric
functions of larynx. Since the popularisation of
supracricoid laryngectomy, there has been a shift in
this concept as explained subsequently.
4. Adhere to Standard resection technique to achieve
expected functional outcome-even if this involves
resection of normal (uninvolved) tissue.
Limitations of the current staging systems [5]:
1. Difference in histology and clinical behaviour
between in-situ carcinoma and severe dysplasia can be
unclear and this is not reflected by T-staging
2. Anterior commissure (AC) involvement has no
impact on the T-stage of the tumour even though this
is associated with poor cure and local control rates
compared to equivalent lesions without AC involve-
ment. In a study in 2005, Barbosa et al showed that up
to 60% patients with AC lesions were understaged on
endoscopic examination. The use of 1 mm thick refor-
matted CT scan images was shown to double the
laryngoscopic accuracy in staging the cancer. [6]
3. Motion impairment is a subjective measure with
inter-observer variation accounting for possible stag-
ing errors of lesions between T1-2 and T2-3.
4. Size of lesion and its molecular characterisation (eg
over-expression of p53 oncogene) are important
determinants of tumour behaviour. These factors have
not been accommodated in T-staging, which is based
entirely on involvement of various subsites within and
outside the laryngeal framework.
Patient evaluation
This should include:
Organ preservation strategies for Ca larynx Figure 1
Organ preservation strategies for Ca larynx. A chart of the overview of management strategies for organ preservation 
surgery for laryngeal cancer
Vertical Partial Laryngectomy
Supraglottic Laryngectomy
Supracricoid Laryngectomy
Open/External
Transoral Laser Microsurgery-TLM
Transoral Robotic Surgery-TORS
Powered/Microdebrider excision
Coblation excision
Endoscopic
Surgical
Radiotherapy
+/-Chemotherapy
Nonsurgical
Organ Preservation StrategiesHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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1. Thorough history
2. Dynamic Assessment of larynx: Fibre optic laryngos-
copy, Indirect laryngoscopy, Stroboscopic evaluation
3. Static Assessment of larynx: Direct laryngoscopy
4. Imaging: CT, MRI, PET
5. Head and Neck examination
6. Exclusion of synchronous lesion in upper aero-
digestive tract
7. General medical evaluation:
a. Lung function
b. Cardiac status
c. Social assessment
d. Motivation to participate in rehabilitation
e. Occupational use of voice
f. Nutritional status
g. Alcohol & Tobacco intake
Vertical Partial Laryngectomy (VPL)
Gordon Buck performed laryngofissure and local excision
of laryngeal cancer in 1851. Solis-Cohen in 1869 and Bil-
roth in 1878 introduced transcervical VPL and achieved
long-term cure of glottic cancer. [7,8] Description of the
modern technique of VPL is attributed to Som (1951).
VPL encompasses a spectrum of procedures ranging from
laryngofissure with cordectomy to extended hemilarynge-
ctomy. Common to all these procedures is vertical
transection of thyroid cartilage and glottic resection
extending into the paraglottic space. The goal of the sur-
gery is resection of a portion of thyroid cartilage with the
cancer at glottic level while preserving the posterior para-
glottic space. Hence, it is most suitable for early glottic
cancer (T1 and some T2 lesions) without fixation of mem-
branous true vocal cords and without anterior commis-
sure involvement.
A classification system has been proposed for VPL based
on the extent of resection (Type 1: Standard vertical; Type
2: Fronto-lateral; Type 3: Antero-frontal; Type 4:
Extended- any procedure where one arytenoid is taken).
[8] Subsequent discussion predominantly applies to the
Fronto-lateral VPL-the most common variant.
Indication [9]
1. Large T1 glottic cancer- best results obtained when
lesion is confined to middle third of vocal cord
2. Small T2 glottic cancer with minimal extension into
supraglottis/subglottis
3. Early glottic cancer difficult to visualise endoscopi-
cally
4. Resection can be extended both anteriorly and pos-
teriorly as well as beyond glottis
5. Salvage for radiotherapy failure of early-intermedi-
ate glottic cancer
Contra-indications [10]
1. Involvement of Crico-arytenoid joint
2. Involvement of thyroid cartilage
3. Involvement of more than 1/3rd of contralateral
vocal cord
Failure rates are higher when:
1. Anterior commissure is involved due to propensity
of these tumors to involve subglottis
2. Impaired vocal cord mobility due to involvement of
paraglottic space (thyroarytenoid muscle)
It is worth mentioning here that the recurrence rates have
been quoted as high as 17–40% for intermediate (T2)
lesions and VPL is being replaced by Supracricoid larynge-
ctomy in many centres. [11]
Surgical Technique
A tracheotomy may or may not be required. If an attempt
to avoid a tracheotomy is chosen, a prophylactic thyroid
isthmectomy can be performed in case tracheostomy is
required at a later stage. [3] The role of a Cook's airway
exchange catheter has been studied to avoid the need for
a tracheotomy. [12]
A transverse skin incision and subplatysmal flaps are
raised. The strap muscles are separated and prelaryngeal
tissue containing Delphian node is removed and sent for
histopathology (ideally for frozen section). The thyroid
cartilage is exposed and either a laryngofissure is made
using a midline or paramedian incision or a large window
is created in the thyroid cartilage lamina. [see figure 2] The
Anterior-Posterior resection includes anterior commissure
including the membranous vocal cord and intrinsic laryn-
geal musculature up to the vocal process of arytenoid.Head & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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Superior-Inferior resection is carried from upper surface of
false cord to 5 mm below the edge of vocal cord. The ary-
tenoid cartilage may be spared or excised either partially
or completely. [see figure 3]
Reconstruction [see figure 4]
The petiole of epiglottis is sutured anteriorly to prevent
posterior prolapse and supraglottic stenosis. The divided
edges of the false and true cords on the uninvolved side
are sutured to the external layer of perichondrium. Vari-
ous materials can be used for reconstruction of glottis on
the involved side: Pedicled/Bi-Pedicled muscle flap (Ster-
nohyoid flap); Mucosal flap (false vocal cord); Epiglottic
flap; Deep cervical fascia [13]; Corniculate-Cuneiform
flap [14]; free tissue transfer. A laryngeal keel may be used
to prevent the formation of adhesions anteriorly, but is
rarely required with good surgical technique. In absence
of a tracheostomy, the skin wound can be closed loosely
to allow air leak and prevent subcutaneous emphysema.
When reconstructing the glottis, the surgeon should be
mindful of avoiding excessive soft tissue bulk, which can
cause airway compromise.
VPL offers several advantages over radiotherapy for man-
agement of early glottic cancer [13]:
1. Pathological staging of cancer possible
2. Easier to look for recurrence
3. Lower cost
4. Single treatment modality usually curative
5. Higher organ preservation rate
Complications
1. Wound related: infection, seroma/hematoma, cervi-
cal skin necrosis
2. Significant subcutaneous emphysema can result
3. Laryngocele
4. Laryngeal stenosis
Saggital saw used to cut the thyroid cartilage in vertical par- tial laryngectomy Figure 2
Saggital saw used to cut the thyroid cartilage in verti-
cal partial laryngectomy.
Removal of lamina of thyroid cartilage on the cancer bearing  side Figure 3
Removal of lamina of thyroid cartilage on the cancer 
bearing side. N/A
'Pexy' in vertical partial laryngectomy Figure 4
'Pexy' in vertical partial laryngectomy. Closure of the 
contralateral retained hemilarynx.Head & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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Endoscopic VPL is discussed under 'Endoscopic Manage-
ment of laryngeal cancer.'
Supraglottic Laryngectomy (SGL), partial 
horizontal laryngectomy
It was first described by Alonso in 1947 as a two-stage pro-
cedure and modified by Ogura in 1957 to single stage
[15]. Som (1959) [10] and Bocca (1968) [16], made fur-
ther refinements to the technique. This led to its wider
acceptance as an oncologically sound procedure for inter-
mediate stage supraglottic cancer. [7] Post-surgical voice
quality is good as the vocal cords are preserved.
Supraglottic cancer poses unique management issues due
to:
1. Association with pre-epiglottic and paraglottic
spaces
2. A rich lymphatic supply which is independent of the
rest of larynx (leading to a higher risk of metastasis
and recurrence) [15]
3. Distinct anatomical boundaries due to its embryo-
logical origin from buccopharyngeal anlage
4. The need for treatment of the N0 neck with either
adjuvant (chemo)-radiotherapy or selective neck dis-
section
Contra-indication: [17]
1. Involvement of cricoid +/- thyroid cartilage
2. Impaired mobility/Fixity of vocal cords
3. Impaired tongue base mobility; Cancer within 1 cm
of circumvallate papilla
4. Mucosal invasion of bilateral arytenoids
5. Involvement of anterior and posterior commissure;
Extension to glottis
Surgical Technique
Resection generally includes removal of the whole epi-
glottis, false cords, ary-epiglottic folds, pre-epiglottic
space, and upper half of the thyroid cartilage +/- hyoid
bone. [16] However, it can be tailored according to the
tumour extent and involvement of the various subsites.
Following skin incision and flap elevation, upper half of
thyroid cartilage is exposed and the perichondrium is
reflected down with the infrahyoid strap muscles. [see fig-
ure 5] The inferior constrictor is separated from lateral and
postero-superior margins of thyroid cartilage, releasing
the pyriform sinuses to the level of the laryngeal ventricle.
Care is taken to preserve the main trunks of superior
laryngeal nerve. The anterior commissure is identified and
the thyroid cartilage is divided along an oblique line
towards its superior cornu. [see figure 6] If the pre-epiglot-
tic space appears to be involved, the hyoid bone is
resected with its overlying strap muscles. If oncologically
sound, the hyoid is preserved to assist in reconstruction.
The pharynx is entered at the level of the vallecula. The
ary-epiglottic fold on the uninvolved side is transected
anterior to the arytenoid and the dissection is brought
anteriorly along the plane of thyroid cartilage incision.
Perichondrium reflected to expose thyroid cartilage Figure 5
Perichondrium reflected to expose thyroid cartilage.
Saggital saw used to cut the thyroid cartilage in supraglottic  laryngectomy Figure 6
Saggital saw used to cut the thyroid cartilage in sup-
raglottic laryngectomy.Head & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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Reconstruction
If possible, preservation of the hyoid provides a sturdier
repair. The tongue base is sutured so as to impact onto the
thyroid cartilage and act as a shelf to prevent aspiration.
This allows food to be channelled into the pyriform
sinuses. The laryngeal remnant should be positioned as
far superiorly and anteriorly as possible. [see figure 7]
Complications
1. Aspiration:
-Mild to moderate aspiration has been reported in
67–100% cases [18]
-Low grade, chronic aspiration may require inten-
sive rehabilitation including "supraglottic swal-
low" where patient is instructed to cough after each
swallow.
-Prolonged tracheostomy +/- PEG may be required
2. Long-term failure to develop physiologic degluti-
tion may require a completion laryngectomy.
Supracricoid Laryngectomy (SCPL)
SCPL was first described in 1959 by two Austrian sur-
geons, Majer and Rieder as an organ preservation surgery
involving cricohyoidopexy in order to avoid a permanent
tracheostomy. [19] It was received with initial enthusiasm
however, as the functional and oncologic results were not
encouraging, it fell into disrepute. Through the 1970s,
French surgeons Labayle and Piquet modified the tech-
nique and thereafter, it was widely adopted in France
(known as Subtotal Laryngectomy). In 1980s Laccourreye
brought together these modifications and standardized
the reconstruction as Cricohyoidopexy (CHP) or Cricohy-
oidoepiglottopexy (CHEP). The procedure was accepted
and popularised in USA during 1990s through work of
surgeons such as Tufano. [20]
SCPL bridges the gap between partial open procedures
and total laryngectomy (TL). [4] Results published in con-
temporary literature show that management of patients
with intermediate-advanced laryngeal cancer with con-
ventional organ preservation techniques such as radio-
therapy or vertical partial laryngectomy can result in
unacceptably high incidence of local recurrence. [21,22]
In contrast, SCPL results in excellent and reproducible
local control when its indications are adhered to while
offering superior quality of life. It is now established as a
viable alternative to TL for a significant group of patients.
[23,24]
Definition & Principle
Traditionally, the glottis has been deemed to be the func-
tional unit of larynx in order to maintain physiologic
speech and sphincteric function while swallowing. The
concept of the Crico-Arytenoid unit (CAU) as the func-
tional subunit of larynx is relatively new to the English lit-
erature but has been in vogue internationally since the
1990s. The vocal ligament and thyroarytenoid muscles
provide refinement and exquisiteness to the range of
speech. But the driving force for phonatory function is a
mobile and sensate CAU. (see table 1)
According to this concept, speech and swallowing can
made possible by preservation of one or both CAU with
special attention to the attachment of posterior and lateral
cricoarytenoid muscles – to allow the neo-glottis to
abduct/adduct postoperatively. For a good functional out-
come, all these structures (muscular, neovascular, carti-
lages) must be preserved
Through anatomical-pathological studies, it has been
shown that the cord fixation in laryngeal cancer results
from involvement of the para-glottic space and invasion
'Pexy' in supraglottic laryngectomy Figure 7
'Pexy' in supraglottic laryngectomy. Suturing of the 
amputated larynx to the tongue base in supraglottic laryngec-
tomy.
Table 1: The Crico-Arytenoid Unit (CAU)
Cartilage B Cricoid-signet ring
B Arytenoids (+ Corniculate/Cuneiform)
Muscles B Posterior cricoarytenoid
B Lateral cricoarytenoid
B Inter arytenoids
Nerves B Recurrent laryngeal nerve
B Superior laryngeal nerveHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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of the thyroarytenoid muscle. One of the main oncologic
concepts of SCL is the excision of the entire para-glottic
space, hence the thyroarytenoid muscle. It also allows
complete excision of the lateral and posterior cricoaryten-
oid muscles if the arytenoid on the tumour bearing side is
disarticulated and excised.
In SCPL, membranous vocal cords, false cords and para-
glottic spaces are excised (along with the entire thyroid
cartilage). In addition, the pre-epiglottic space and epi-
glottis can be completely excised (although the lower 1/
3rd of epiglottis is preserved in a CHEP). The arytenoid on
the tumour-bearing side can be excised as governed by the
requirement of an oncologic resection. However, it is
absolutely essential to preserve one intact and sensate
CAU and the cricoid cartilage. [25]
Laryngeal reconstruction is accomplished using elements
of the preserved crico-arytenoid unit(s) and a crico-hyoid
impaction. For wound closure a "pexy" is done between
cricoid and hyoid alone (SCPL-CHP) or using preserved
portion of epiglottis to intervene between cricoid and
hyoid (SCPL-CHEP). In selected cases, the anterior arch of
cricoid can be resected and a tracheo-cricohyoidoepiglot-
topexy (TCHEP) done by incorporating tracheal ring into
the "pexy". Non-absorbable sutures (eg. Prolene) should
be used to prevent wound breakdown and subsequent
aspiration.
Compared to VPL, SCPL provides a more comprehensive
resection of the para-glottic space; it can be used for can-
cers extending to the anterior commissure and can even be
used for selective T4 lesions with minimal thyroid carti-
lage invasion (although this remains controversial). SCPL
meets the criteria of organ preservation; it restores physio-
logical speech and swallowing and there is no need for a
long-term tracheostomy.
Indication of SCPL [4,10]
It is important to realise that the surgical management is
dictated by peri-operative 3-D tumour assessment and not
by the T staging of the cancer. Surgeons should be well
familiar with the technique as it is technically more
demanding than other forms of partial laryngeal surgery.
1. T1b/T2/T3 Glottic/Transglottic/Supraglottic cancer
(when Supraglottic Laryngectomy is not appropriate)
2. Selected T4 Ca larynx-limited invasion of thyroid
ala without extension through outer thyroid perichon-
drium
3. Salvage after radiotherapy failure [26-28]
Contraindication [4,29]
1. Involvement of interarytenoid space; posterior com-
missure; mucosal involvement of B/L arytenoids
2. Fixed arytenoids
3. Subglottic extension (>10 mm anteriorly or >5 mm
posteriorly)
4. Extra-laryngeal spread
5. Invasion of Hyoid bone
6. Invasion of the pre-epiglottic space; Tumour origi-
nating from the epi-larynx Note: excludes a CHEP-
CHP still possible)
Surgical Technique
The trachea needs to be released more inferiorly than
usual, taking care not to disturb RLN and inferior thyroid
artery (cervico-mediastinal release). This allows the anas-
tomosis to be performed without tension. The involved
arytenoid needs to be excised; however, an attempt to pre-
serve its posterior mucosa should be made if oncologi-
cally feasible. This can serve as a buttress to stabilise the
contralateral arytenoid. A releasing incision is performed
along the lateral edges of thyroid cartilage and the crico-
thyroid joint is disarticulated. The endolarynx entered
through the cricothyroid membrane at the superior edge
of cricoid to maximise the amount of inferior glottic
mucosal margin.
The planned type of repair determines the site of the inci-
sion of thyrohyoid membrane:
1. CHEP: Tran epiglottic laryngotomy (just above the
thyroid cartilage)
2. CHP: Trans-vallecular pharyngotomy (just below
hyoid)
Care should be taken not to injure the SLN (according to
some surgeons, dissection performed to specifically iden-
tify the nerve can cause bleeding and attempts to maintain
hemostasis can result in nerve injury). Injury to the SLN
leads to pooling in PFS and has been associated with a
higher incidence of aspiration and swallowing impair-
ment. [30] The AE folds are divided and bilateral ventri-
cles inspected. Care is taken not to leave any mucosa
behind to prevent laryngocele formation.
Reconstruction [see figure 8]
The arytenoid(s) need to be resuspended, as they tend to
fall posteriorly due to the loss of thyro-arytenoid muscle.
It is crucial to create a T shaped valve that will close againstHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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the epiglottis/base of tongue. The Arytenoids should not,
however, be placed in contact with each other as post-
operative synechiae can result in stenosis. Cricopharyn-
geal myotomy is done at the surgeon's discretion if hyper-
tonia is detected in which case anti-reflux therapy should
be commenced post-operatively. The 'pexy' is performed
by placement of 3 or 5 impaction stitches approximately
8–10 mm apart, passing inferior to superior. An "inverted-
funnel" shape of pyriform sinus is important for the pha-
ryngeal phase of swallowing. This needs to be restored
after SCPL. Two (3–0) Vicryl sutures are placed in fascia of
inferior constrictor after impaction has been done and are
tied anteriorly to the contralateral stitch. Pulling the lat-
eral pharyngeal wall anteriorly restores its physiologic
position and the function of inferior constrictors and PFS.
A tight dressing is recommended to prevent surgical
emphysema.
Physiologic Aspects
Following SCPL, speech is generated by the periodic
mucosal wave on the anterior aspect of arytenoid cartilage
where it abuts epiglottis (Ary-epiglottic type phonation).
It is comparable to normal speech for average fundamen-
tal frequency. However, it is less efficient in range, jitter,
shimmer, noise: harmonics ratio, maximum phonation
time, speech rate and phrase grouping. [19]
Swallowing is usually restored in 2–3 weeks and requires
intense rehabilitation. Prolonged requirement for feeding
tube and tracheostomy is more common in previously
irradiated patient undergoing salvage surgery.
SCPL has been shown to offer higher quality of life com-
pared to TL. [10] In a study of quality of life assessment,
higher score were given for physical and social function-
ing by patients undergoing SCPL; physical and general
health and better voice quality compared to patients with
TL. [24] Several studies have shown the local control and
survival rates to be similar to TL.
Complication
1. Stenosis – more likely in females (due to smaller air-
way) and in previously irradiated patients
2. Aspiration => pneumonia, failed decannulation,
completion laryngectomy
3. Non-achievement of physiologic deglutition =>
may require long term/permanent PEG feeding
Radiotherapy after SCPL is associated with negative influ-
ence on functional outcome and direct correlation has
been demonstrated between radiotherapy dose and com-
plication rate after laryngeal preservation surgery. [31]
Role of endoscopic surgery in management of 
laryngeal cancer
Horace Green was the first surgeon to attempt transoral
resection of laryngeal tumor in 1852. [32] In 1886, Fraen-
kel utilised indirect laryngoscopy to excise laryngeal can-
cer. Kirstein designed endoscopes to visualise larynx in
1890s and suspension laryngoscopy was used by Lynch in
1915. [33] Microscope was added to improve visualisa-
tion in the following decades. In 1972, Jako and Strong
pioneered the use laser for endoscopic resection popular-
ising the CO2 laser. Vaughan introduced the technique for
endoscopic management of supraglottic cancer in 1978.
Endoscopic technique was perceived to violate the tenets
of oncological resection, and this led to initial hesitation
in its application for organ preservation. Other drawbacks
of the technique included limited exposure and poor
access to anterior commissure and the posterior paraglot-
tic space.
It was subsequently shown that piecemeal excision of a
tumour did not have any adverse effect on the loco-
regional control and survival rates. In fact, tumours larger
than the size of the laryngoscope could be excised thus.
Steiner has advocated that the laser settings should be
adjusted to excise the lesion rather than vaporise the tis-
sues; furthermore, transection of tumour leads to a more
accurate assessment of the depth of invasion thereby
ensuring clearance at the deep margins. [34]
In the larynx, the technique involves complete excision of
the lesion ideally with 2–3 mm circumferential margins.
'Pexy' in supracricoid laryngectomy Figure 8
'Pexy' in supracricoid laryngectomy. Cricoid ring is 
sutured to the hyoid and tongue base to reconstruct the 
laryngeal airwayHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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Particular attention is paid to the accurate orientation of
the specimens. Biopsies are sent from the tumour bed for
frozen section histopathological analysis. Positive mar-
gins necessitate a further surgical resection. [35] Manage-
ment of nodal disease should be as per the conventional
protocols although some surgeons choose to stage the
neck dissection. [36]
Endoscopic laser microsurgery has been reported to
achieve local control rate in the range of 80–94% and
organ preservation rate in up to 94% cases. [37] An impor-
tant advantage of this procedure is that in the event of
local recurrence, in leaves open all other treatment
options for laryngeal cancer including laser re-excision.
Endoscopic Vertical Partial Laryngectomy (EVPL) has
evolved concurrently with the increasing expertise of sur-
geons in transoral laser resection of early laryngeal cancers
and provides an organ preservation option for early-inter-
mediate glottic cancer (T1, 2). [35] Exposure of the ante-
rior commissure is enhanced with bilateral excision of
vestibular folds +/- inferior epiglottectomy as developed
by Kashima. The superior edge of thyroid cartilage is
exposed and microdissection of the inner perichondrium
is feasible. Cartilage invasion can be ascertained by direct
visualisation and if needed, cartilage can be excised at the
anterior commissure. Further refinement in technique,
such as excision of the aryepiglottic folds for tumours with
extensive posterior involvement can uncap the posterior
paraglottic space. Additional treatment is usually indi-
cated for tumours with extensive antero-inferior or pos-
tero-lateral spread. Phonosurgical options include
medialisation laryngoplasty, lipoinjection and thyroid
lamina subluxation.
Endoscopic Supraglottic Laryngectomy (ESGL) was first
described by Jackson and Jackson in 1939. [16] It can be
used to excise smaller lesions of the suprahyoid epiglottis,
false cords and aryepiglottic folds. As most of the laryngo-
scopes are designed to provide good exposure of the glot-
tis, a bivalved laryngoscope (introduced by Steiner and
further modified by Zeitels and Vaughn who called it a
"supraglottiscope") may be required to adequately visual-
ise the tumour.
Apart from organ preservation, endoscopic technique
potentially obviates the need for tracheostomy. It also pre-
serves the sensory innervation and normal suspension of
larynx. This results in shorter hospital stay, better swal-
lowing outcome and favourable impact on patient's psy-
chological profile. The oncological results obtained are
comparable to open techniques and radiotherapy. Post-
operative voice quality is variable and depends on the
extent and level of resection. [see figure 9]
Non-laser endoscopic resection
Powered microdebriders have been used for management
of benign laryngeal tumors such as papillomas with great
success. They can be used for endoscopic debulking of
laryngeal cancer with potential advantages including: con-
trolled resection of small superficial lesions, elimination
of the risk of airway fire and thermal injury. However,
their use have not been demonstrated for routine onco-
logical resection of tumours.
Radiofrequency ablation (Coblation)
Radiofrequency coblation is a new and emerging tech-
nique that has been applied with success for the surgical
management of selected oral cavity and pharyngeal malig-
nancies. An orthopaedic 3-electrode Coblator I probe
(with suction only) has been adapted for the excision of
small to intermediate laryngeal and hypopharyngeal can-
cer. [38] It offers advantages such as minimal or no dam-
age to the surrounding tissues, lack of charring in the
tissue bed, haemostasis and superior post-op pain control
in comparison to laser and diathermy. It is also signifi-
cantly quicker than other methods of endoscopic tumour
resection. [38]
The wand carves a 2–3 mm channel of vaporised tissue at
the resected margin. Hence, even if adequate clearance
had been achieved surgically, the pathologist can call the
margins into question. The wand tip is placed in saline gel
to create an adequate environment for the coblation
plasma field; the gel needs to be applied repeatedly to the
instrument. The length of the instrument is long enough
to reach 4 cm below the vocal cords and its current design
is unsuitable to cut through the laryngeal cartilage. It is
hoped that specially designed Coblator II probes (with
Transoral laser excision of supraglottic cancer Figure 9
Transoral laser excision of supraglottic cancer. N/AHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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irrigation and suction) will allow a lot of the above tech-
nical limitations to be overcome.
Role of chemo-radiotherapy in organ 
preservation
This article is not a comprehensive review of the Chemo-
radiotherapy options for management of laryngeal cancer;
some pertinent issues have been discussed here.
Radiotherapy (RT) became popular in 1930s at a stage
where total laryngectomy was fraught with many compli-
cations. It has always been considered the standard for
organ preservation in management of early laryngeal can-
cer against which conservative surgical techniques are
compared. Its efficacy has increased over the recent dec-
ades through the use of neo-adjuvant chemotherapy and
hyperfractionation protocols. Local control rates of > 90%
are achieved for T1 and > 80% for T2 lesion. [39,40] One
study has claimed that long-term quality of life may be
superior with chemo-radiotherapy compared to RT + Sur-
gery. [41] Factors affecting outcome of primary RT are AC
involvement, impaired vocal cord mobility, tumour bulk
and fraction size. [33,42]
It used to be generally agreed that the voice quality follow-
ing primary RT was superior to open partial procedures.
This view has been challenged in recent studies. A meta-
analysis conducted in 2006 showed that both RT and
endoscopic laser microsurgery provide comparable level
of voice handicap for T1 glottic cancers. [43]
The basis of voice impairment following irradiation is the
damage to microstructure of the vocal cords (fibrosis,
oedema, and irregularity in the vocal folds) impairing the
generation of the mucosal wave. Other factors contribut-
ing to poor voice quality include loss of salivary glands
and mucositis. Surgery offers the advantage of sparing
trauma to the uninvolved cord as well as providing phon-
osurgical options to repair the post surgical defects.
In another meta-analysis study by Luscher et al, treatment
of T1 glottic cancer using radiotherapy and laser were
compared. Laser was found to be the cheaper option with
lower recurrence rates. However, in three out of six stud-
ies, radiotherapy resulted in superior voice quality (In
remaining three studies, no difference was noted). [44]
Higher overall cost of RT has been reported in other stud-
ies as well. [45]
Disadvantages of RT include:
1. It cannot be repeated
2. Failure rates with primary RT have been reported as
high as 29% [28]
3. The risk of over-treating early glottic cancer com-
pletely excised by diagnostic biopsy
4. Post-RT changes make follow up and detection of
recurrence difficult and endoscopic examination
alone may be insufficient for assessment
Future directions
Robotics in ENT: TORS
Robotics has recently been introduced in surgical special-
ties such as cardiac surgery and urology. The feasibility of
robotics (da Vinci robotics system, Intuitive Surgical Inc,
California) in the surgery of upper aero-digestive tract has
been performed based on research conducted in canine
models and human cadavers. The acronym TORS (Tran-
soral Robotic Surgery) was coined by Weinstein et al and
is defined as surgery done per orally using a minimum of
three robotic arms and allows for bimanual surgical tech-
nique. [46]
A pilot study was conducted at the Department of ENT,
University of Pennsylvania in 2005. Three patients with
laryngeal cancer (T2-3) underwent partial supraglottic
laryngectomy. Robotics offers technical advantages such
as:
￿ Realistic 3-D imaging
￿ Motion scaling
￿ 6° of motion around the "wristed' working ends of the
instruments (thus natural hand movements are trans-
ferred to the operative field)
￿ Tremor filtration
Thus it attempts to overcome the shortcomings of the
TLM in technically challenging cases where visualisation
is inadequate due to difficult anatomy. Moreover, the
"fulcrum effect" of conventional endoscopic surgery is
avoided. At present, the major disadvantages of the tech-
nique include the cost, which limits its wider application.
The lack of natural tactile feel is another potential draw-
back, although it has been argued that the high-resolution
3-D imaging provides superior visual cues and compen-
sates for the lack of feedback. Nonetheless, the technical
feasibility and safety of Robotics in the surgery of upper
aero-digestive tract has been established through the pio-
neering work of Weinstein et al. [46,47]
Role of optical diagnostics
Oncologic resection aims to achieve uninvolved margins,
as this is an important prognostic factor to reduce likeli-
hood of loco-regional recurrence. Sites prone to local
relapse are subjected to wider resection keeping with theHead & Neck Oncology 2009, 1:12 http://www.headandneckoncology.org/content/1/1/12
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tenets of en bloc removal of cancer. This however, is inad-
equate to predict clinical outcome and cancers have been
known to recur despite adequate resection and unin-
volved margins. Better understanding of the tumour biol-
ogy has led to appreciation of its behaviour and
aggressiveness.
The difference in the tumour and normal tissue at the sub-
cellular level is being utilised by current research tools to
aid diagnosis and screening of cancer. While most of these
techniques are not yet available for routine use in the out-
patient clinics and operating theatres, they offer an
immense advantage in the accurate staging of the disease.
The implications for organ preserving surgery are appar-
ent given the ability to assess tissues in real time and in
situ.
These techniques offer the possibility to enable clinicians
to (a) screen mucosa surfaces (b) permit targeted biopsy
(c) assessment of resected tumour margins and (d) the
ability to perform 'optical biopsy' by providing diagnostic
signatures of disease, thus eliminating the need for frozen
sections and paraffin sections. [48]
Elastic Scattering Spectroscopy (ESS) has been used to
study oral [49] and esophageal [50] lesions extensively. Its
underlying principle is the different scattering and absorp-
tive properties of normal and abnormal tissues for light
energy. An optical probe gathers the reflected light and a
wavelength dependent spectrum is generated. Published
results show that ESS is superior to other optical diagnos-
tic techniques in detecting dysplasia.
Fluorescence Spectroscopy [51] is based on tumour spe-
cific distribution of fluorophores such as collagen, elastin
and tryptophan to distinguish between normal and malig-
nant tissues. The difference between malignant and nor-
mal tissues can be accentuated by administering 5-
aminolaevulinic acid (ALA), which is preferentially taken
up by cancer cells resulting in increased red fluorescence.
Presence of chronic inflammation can confound results
and confer low specificity limiting the use of this tech-
nique as a screening tool only. It can however, be com-
bined with other optical diagnostics modalities to
enhance specificity.
Conclusion
Numerous competing modalities are available for treat-
ment of early-intermediate laryngeal cancer with equiva-
lent success rates and proven efficacy. The lack of
randomised control trials comparing various treatment
options necessitates that the decision of choosing a partic-
ular approach depends on factors such as patient's prefer-
ence, available resources, cost of treatment, established
local protocols, surgeon's experience and skills rather than
evidence based medicine alone. Todays' Head & Neck Sur-
geon has a large armament of options, to consider and a
total laryngectomy is now a necessity for a small percent-
age of patients. Molecular characterisation of individual
tumours, such as the association between EGFR (epider-
mal growth factor receptor) and radio-resistance [52,53] is
likely to play an important role in the near future to deter-
mine the aggressiveness of disease and the best outcomes
from a variety of treatment options.
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